[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Lateral Flow Assay (LFA) Market 2023-2029

March 2023 | 64 pages | ID: GD59FBC84633EN
Gen Consulting Company

US$ 2,850.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Lateral flow assay (LFA) is a diagnostic test that uses a paper-based strip to detect the presence of a specific biomarker or analyte in a sample. Lateral flow assays are commonly used in medical diagnostics, food safety testing, and environmental monitoring. The global lateral flow assay market size is projected to grow by USD 2.0 billion from 2023 to 2029, registering a CAGR of 3.13 percent, according to the latest market data. Lateral flow assays are rapid, portable, and require minimal equipment, making them ideal for use in settings with limited resources or in remote locations.Lateral flow assays are rapid, portable, and require minimal equipment, making them ideal for use in settings with limited resources or in remote locations.

The report covers market size and growth, segmentation, regional breakdowns, competitive landscape, trends and strategies for global lateral flow assay market. It presents a quantitative analysis of the market to enable stakeholders to capitalize on the prevailing market opportunities. The report also identifies top segments for opportunities and strategies based on market trends and leading competitors’ approaches.

This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the product, technology, application, end user, and region. The global market for lateral flow assay can be segmented by product: kits and reagents, readers. In 2022, the kits and reagents segment made up the largest share of revenue generated by the lateral flow assay market. Lateral flow assay market is further segmented by technology: sandwich assays, competitive assays. The sandwich assays segment was the largest contributor to the global lateral flow assay market in 2022. Based on application, the lateral flow assay market is segmented into: clinical diagnostics, food safety, veterinary diagnostics, others. The clinical diagnostics segment is estimated to account for the largest share of the global lateral flow assay market. On the basis of end user, the lateral flow assay market also can be divided into: hospitals and clinics, home healthcare, diagnostic laboratories, food and beverages companies, pharma & biotech companies, others. The hospitals & clinics segment held the largest share of the global lateral flow assay market in 2022 and is anticipated to hold its share during the forecast period. Lateral flow assay market by region is categorized into: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America.

Market Segmentation
By product: kits and reagents, readers
By technology: sandwich assays, competitive assays
By application: clinical diagnostics, food safety, veterinary diagnostics, others
By end user: hospitals and clinics, home healthcare, diagnostic laboratories, food and beverages companies, pharma & biotech companies, others
By region: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America

The report explores the recent developments and profiles of key vendors in the Global Lateral Flow Assay Market, including Abbott Laboratories, F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Siemens Healthineers AG, QuidelOrtho Corporation, among others. In this report, key players and their strategies are thoroughly analyzed to understand the competitive outlook of the market.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Scope of the Report
To analyze and forecast the market size of the global lateral flow assay market.
To classify and forecast the global lateral flow assay market based on product, technology, application, end user, region.
To identify drivers and challenges for the global lateral flow assay market.
To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global lateral flow assay market.
To identify and analyze the profile of leading players operating in the global lateral flow assay market.

Why Choose This Report
Gain a reliable outlook of the global lateral flow assay market forecasts from 2023 to 2029 across scenarios.
Identify growth segments for investment.
Stay ahead of competitors through company profiles and market data.
The market estimate for ease of analysis across scenarios in Excel format.
Strategy consulting and research support for three months.
Print authentication provided for the single-user license.
PART 1. INTRODUCTION

Report description
Objectives of the study
Market segment
Years considered for the report
Currency
Key target audience

PART 2. METHODOLOGY

PART 3. EXECUTIVE SUMMARY

PART 4. MARKET OVERVIEW

Introduction
Drivers
Restraints

PART 5. MARKET BREAKDOWN BY PRODUCT

Kits and reagents
Readers

PART 6. MARKET BREAKDOWN BY TECHNOLOGY

Sandwich assays
Competitive assays

PART 7. MARKET BREAKDOWN BY APPLICATION

Clinical diagnostics
Food safety
Veterinary diagnostics
Others

PART 8. MARKET BREAKDOWN BY END USER

Hospitals and clinics
Home healthcare
Diagnostic laboratories
Food and beverages companies
Pharma & biotech companies
Others

PART 9. MARKET BREAKDOWN BY REGION

North America
Europe
Asia-Pacific
MEA (Middle East and Africa)
Latin America

PART 10. KEY COMPANIES

Abbott Laboratories
F. Hoffmann-La Roche AG
Thermo Fisher Scientific Inc.
Siemens Healthineers AG
QuidelOrtho Corporation

DISCLAIMER


More Publications